Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis
Clinical trial NCT01433445 · COMPLETED
Trial details
- NCT number
- NCT01433445
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2020-06-22
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.